Trexquant Investment’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-71,224
| Closed | -$353K | – | 1756 |
|
|
2022
Q1 | $353K | Buy |
+71,224
| New | +$353K | 0.02% | 924 |
|
|
2021
Q4 | – | Sell |
-36,840
| Closed | -$368K | – | 1534 |
|
|
2021
Q3 | $368K | Buy |
36,840
+20,554
| +126% | +$205K | 0.03% | 658 |
|
|
2021
Q2 | $231K | Sell |
16,286
-14,977
| -48% | -$212K | 0.02% | 839 |
|
|
2021
Q1 | $513K | Buy |
+31,263
| New | +$513K | 0.05% | 498 |
|
|
2020
Q4 | – | Sell |
-32,791
| Closed | -$250K | – | 1362 |
|
|
2020
Q3 | $250K | Buy |
32,791
+20,539
| +168% | +$157K | 0.02% | 1002 |
|
|
2020
Q2 | $102K | Buy |
+12,252
| New | +$102K | 0.01% | 1114 |
|
|
2018
Q4 | – | Sell |
-20,190
| Closed | -$139K | – | 1233 |
|
|
2018
Q3 | $139K | Buy |
+20,190
| New | +$139K | 0.01% | 875 |
|
|
2017
Q1 | – | Sell |
-21,663
| Closed | -$181K | – | 1247 |
|
|
2016
Q4 | $181K | Buy |
+21,663
| New | +$181K | 0.03% | 850 |
|
|
2016
Q1 | – | Sell |
-13,731
| Closed | -$129K | – | 1097 |
|
|
2015
Q4 | $129K | Buy |
13,731
+2,959
| +27% | +$27.8K | 0.01% | 963 |
|
|
2015
Q3 | $151K | Sell |
10,772
-4,928
| -31% | -$69.1K | 0.01% | 988 |
|
|
2015
Q2 | $329K | Buy |
15,700
+6,352
| +68% | +$133K | 0.04% | 782 |
|
|
2015
Q1 | $392K | Buy |
+9,348
| New | +$392K | 0.04% | 777 |
|